CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding CollPlant Biotechnologies Ltd changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 17 | 21 | +4 |
| Shares | 1.38M | 1.53M | +150.1K (+10.9%) |
| Value | $1.93M | $819.0K | −$1.11M (−57.6%) |
New holders (5)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 64,000 | $34.3K | 0.00% |
| Citadel Advisors LLC | 32,165 | $17.2K | 0.00% |
| Two Sigma Securities, LLC | 11,357 | $6.09K | 0.00% |
| Simplex Trading, LLC | 118 | $63 | 0.00% |
| UBS Group AG | 95 | $51 | 0.00% |
Sold out (1)
Institutions that held CollPlant Biotechnologies Ltd at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Bank of America Corp | 2,500 | $3.50K |